GLYC: GlycoMimetics, Inc. Stock

by  •  • Comments Off on GLYC: GlycoMimetics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 25.75
Enterprise Value ($M) 11.36
Book Value ($M) 11.38
Book Value / Share 0.18
Price / Book 2.26
NCAV ($M) 11.32
NCAV / Share 0.18
Price / NCAV 2.27

Profitability (mra)
Return on Invested Capital (ROIC) -3.41
Return on Assets (ROA) -0.75
Return on Equity (ROE) -0.85

Liquidity (mrq)
Quick Ratio 3.62
Current Ratio 3.62

Balance Sheet (mrq) ($M)
Current Assets 15.65
Assets 15.70
Liabilities 4.32
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
6 days ago 13G/A Invus Global Management, LLC 3.00 -62.84
11-06 13G Ra Capital Management, L.p. 9.90
11-04 13D Adage Capital Management, L.P. 7.90
05-08 13D/A New Enterprise Associates 10 L P
02-09 13G/A Artal International S.C.A. 13.30 30.66
01-29 13G/A Biotechnology Value Fund L P 14.80 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Commission file number 001-36177 GlycoM

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 314,799 1,766,547 17.82
2024-11-14 249,777 839,619 29.75
2024-11-13 311,351 942,038 33.05
2024-11-12 168,466 881,034 19.12

(click for more detail)

Similar Companies
FULC – Fulcrum Therapeutics, Inc. GANX – Gain Therapeutics, Inc.
GHRS – GH Research PLC HCWB – HCW Biologics Inc.
HRMY – Harmony Biosciences Holdings, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: GlycoMimetics